Filing Flows › InspireMD (NSPR) › Q4 2024
InspireMD (NSPR) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 12, 2025
InspireMD (NSPR) reported revenue of $1.9M for the fourth quarter 2024 (Q4 2024), +11% from a year earlier and +8% from the quarter before. Operating margin was -480.6%, net loss $9.2M (470.7% of revenue).
InspireMD, Q4 2024: revenue $1.9M (+11% year over year), operating margin -480.6%, net loss $9.2M, operating cash flow −$6.8M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | +8% | +11% |
| Operating profit | −$9.4M | — | — |
| Net earnings | −$9.2M | — | — |
| Operating cash flow | −$6.8M | — | — |
What changed
Revenue was $1.9M in Q4 2024, up 11% year over year and up 8% from the previous quarter.
Gross margin was 24.1%, down 4.6 points from a year earlier. Operating costs exceeded revenue by $9.4M, an operating margin of -480.6%. Operating expenses grew 56% against revenue growth of 11%. The fastest-growing cost line was Research & development (+81%). The quarter ended with a net loss of $9.2M, wider than the previous quarter's $7.9M loss.
Operating cash flow was −$6.8M. Non-cash charges added back $279.8M of depreciation and amortization and $2.3M of share-based compensation. Working capital and other items used $279.7M. Capital expenditures of $311K exceeded it, leaving free cash flow of −$7.1M.
Questions
What was InspireMD's revenue in the fourth quarter 2024?
InspireMD (NSPR) reported revenue of $1.9M for the fourth quarter 2024 (Q4 2024), +11% from a year earlier and +8% from the quarter before.
Was InspireMD profitable in the fourth quarter 2024?
Operating loss was $9.4M (-480.6% of revenue) and net loss $9.2M.
Source: InspireMD 10-K on SEC EDGAR.